Coeptis Therapeutics Holdings, Inc.
COEP
Revenue
237.44k
▲36.76k▲18.32%
3 Months ChangeAssets
14.18M
▲1.99M▲16.32%
3 Months ChangeLiabilities
3.26M
▼-1.85M▼-36.13%
3 Months ChangeFree Cash Flow
-1.68M
▼-722.74k▼-75.15%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-12
Form 8-K
ID: 0001683168-26-000963
2026-02-04
Form 8-K
ID: 0001683168-26-000751
2026-01-16
Form 8-K
ID: 0001683168-26-000370
2025-11-14
Form 10-Q
ID: 0001683168-25-008341
2025-08-14
Form 10-Q
ID: 0001683168-25-006173
2025-05-14
Form 10-Q
ID: 0001683168-25-003565
2025-04-28
Form 8-K
ID: 0001683168-25-002856
2025-03-27
Form 8-K
ID: 0001683168-25-001940
2025-01-24
Form 8-K
ID: 0001683168-25-000537
2025-01-22
Form 8-K
ID: 0001683168-25-000482